| Literature DB >> 29633541 |
Federica Sodano1, Barbara Rolando1, Francesca Spyrakis1, Mariacristina Failla2, Loretta Lazzarato1, Elena Gazzano3, Chiara Riganti3, Roberta Fruttero1, Alberto Gasco1, Salvatore Sortino2.
Abstract
A few compounds in which the nitric oxide (NO) photodonor N-[4-nitro-3-(trifluoromethyl)phenyl]propane-1,3-diamine is joined to the mitochondria-targeting alkyltriphenylphosphonium moiety via flexible spacers of variable length were synthesized. The lipophilicity of the products was evaluated by measuring their partition coefficients in n-octanol/water. The obtained values, markedly lower than those calculated, are consistent with the likely collapsed conformation assumed by the compounds in solution, as suggested by molecular dynamics simulations. The capacity of the compounds to release NO under visible light irradiation was evaluated by measuring nitrite production by means of the Griess reaction. The accumulation of compounds in the mitochondria of human lung adenocarcinoma A549 cells was assessed by UPLC-MS. Interestingly, compound 13 [(9-((3-((4-nitro-3-(trifluoromethyl)phenyl)amino)propyl)amino)-9-oxononyl) triphenylphosphonium bromide] displayed both the highest accumulation value and high toxicity toward A549 cells upon irradiation-mediated NO release in mitochondria.Entities:
Keywords: mitochondria; nitric oxide; phosphonium salts; photoactivation; targeted therapy
Mesh:
Substances:
Year: 2018 PMID: 29633541 DOI: 10.1002/cmdc.201800088
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466